Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Ceribell (CBLL) EBITDA (2023 - 2026)

Ceribell filings provide 4 years of EBITDA readings, the most recent being -$19.9 million for Q1 2026.

  • On a quarterly basis, EBITDA fell 55.5% to -$19.9 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$60.3 million, a 34.96% decrease, with the full-year FY2025 number at -$53.3 million, down 31.64% from a year prior.
  • EBITDA hit -$19.9 million in Q1 2026 for Ceribell, down from -$13.5 million in the prior quarter.
  • In the past five years, EBITDA ranged from a high of -$7.2 million in Q3 2023 to a low of -$19.9 million in Q1 2026.
  • Median EBITDA over the past 4 years was -$12.6 million (2024), compared with a mean of -$11.7 million.
  • Biggest five-year swings in EBITDA: dropped 7.4% in 2025 and later tumbled 55.5% in 2026.
  • Ceribell's EBITDA stood at -$8.4 million in 2023, then crashed by 50.05% to -$12.6 million in 2024, then dropped by 7.4% to -$13.5 million in 2025, then plummeted by 47.17% to -$19.9 million in 2026.
  • The last three reported values for EBITDA were -$19.9 million (Q1 2026), -$13.5 million (Q4 2025), and -$13.3 million (Q3 2025) per Business Quant data.